Association of Serum Vitamin D Concentration with the Final Course of Hospitalization in Patients with COVID-19

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2023 Sep 20

PMID 37727794

Authors

Klaudia Konikowska

Katarzyna Kilis-Pstrusinska

Agnieszka Matera-Witkiewicz

Krzysztof Kujawa

Barbara Adamik

Adrian Doroszko

Krzysztof Kaliszewski

Michal Pomorski

Marcin Protasiewicz

Janusz Sokolowski

Katarzyna Madziarska

Ewa Anita Jankowska

Affiliations

Soon will be listed here.

Abstract

Background: Vitamin D deficiency is a substantial public health problem. The present study evaluated the association between vitamin D concentration and hospitalization and mortality risk in patients with coronavirus disease 19 (COVID-19).

Methods: This study used the COronavirus in LOwer Silesia (COLOS) dataset collected between February 2020 and June 2021. The medical records of 474 patients with confirmed severe acute respiratory syndrome 2 (SARS-CoV-2) infection, and whose vitamin D concentration was measured, were analyzed.

Results: We determined a significant difference in vitamin D concentration between discharged patients and those who died during hospitalization (p = 0.0096). We also found an effect of vitamin D concentration on the risk of death in patients hospitalized due to COVID-19. As vitamin D concentration increased, the odds ratio (OR) for death slightly decreased (OR = 0.978; 95% confidence interval [CI] = 0.540-0.669). The vitamin D concentration cutoff point was 15.40 ng/ml. In addition, patients with COVID-19 and serum 25-hydroxyvitamin D (25(OH)D) concentrations < 30 ng/ml had a lower survival rate than those with serum 25(OH)D ≥ 30 ng/ml (log-rank test p = 0.0018). Moreover, a Cox regression model showed that patients with an estimated glomerular filtration rate (eGFR) ≥ 60 ml/min/1.73 m and higher vitamin D concentrations had a 2.8% reduced risk of mortality (hazard ratio HR = 0.972; CI = 0.95-0,99; p = 0.0097).

Conclusions: The results indicate an association between 25(OH)D levels in patients with COVID-19 and the final course of hospitalization and risk of death.

Citing Articles

Effect of Vitamin D in Long COVID Patients.

Hikmet R, Wejse C, Agergaard J Int J Environ Res Public Health. 2023; 20(22).

PMID: 37998290 PMC: 10671780. DOI: 10.3390/ijerph20227058.

References

Gonzalez E, Sachdeva A, Oliver D, Martin K . Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol. 2004; 24(5):503-10. DOI: 10.1159/000081023. View

Forrest K, Stuhldreher W . Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011; 31(1):48-54. DOI: 10.1016/j.nutres.2010.12.001. View

Dusso A . Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation. Kidney Int Suppl (2011). 2014; 1(4):136-141. PMC: 4089671. DOI: 10.1038/kisup.2011.30. View

Annweiler C, Beaudenon M, Simon R, Guenet M, Otekpo M, Celarier T . Vitamin D supplementation prior to or during COVID-19 associated with better 3-month survival in geriatric patients: Extension phase of the GERIA-COVID study. J Steroid Biochem Mol Biol. 2021; 213:105958. PMC: 8319044. DOI: 10.1016/j.jsbmb.2021.105958. View

Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L . Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020; 97(5):829-838. PMC: 7110296. DOI: 10.1016/j.kint.2020.03.005. View

Levey A, Coresh J, Greene T, Stevens L, Zhang Y, Hendriksen S . Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145(4):247-54. DOI: 10.7326/0003-4819-145-4-200608150-00004. View

Akbari A, Khan M, Adeboye W, Lee L, Chowdhury S . Ethnicity as a risk factor for vitamin D deficiency and undesirable COVID-19 outcomes. Rev Med Virol. 2021; 32(4):e2291. PMC: 8646650. DOI: 10.1002/rmv.2291. View

Petrelli F, Luciani A, Perego G, Dognini G, Colombelli P, Ghidini A . Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies. J Steroid Biochem Mol Biol. 2021; 211:105883. PMC: 7997262. DOI: 10.1016/j.jsbmb.2021.105883. View

Cantorna M . Vitamin D and Lung Infection. Infect Immun. 2016; 84(11):3094-3096. PMC: 5067742. DOI: 10.1128/IAI.00679-16. View

10.

Hafez W, Saleh H, Arya A, Alzouhbi M, Fdl Alla O, Lal K . Vitamin D Status in Relation to the Clinical Outcome of Hospitalized COVID-19 Patients. Front Med (Lausanne). 2022; 9:843737. PMC: 9004341. DOI: 10.3389/fmed.2022.843737. View

11.

Martineau A, Jolliffe D, Hooper R, Greenberg L, Aloia J, Bergman P . Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017; 356:i6583. PMC: 5310969. DOI: 10.1136/bmj.i6583. View

12.

Gois P, Wolley M, Ranganathan D, Seguro A . Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies. Int J Environ Res Public Health. 2018; 15(8). PMC: 6121405. DOI: 10.3390/ijerph15081773. View

13.

Park M, Yoon E, Lim Y, Kim H, Choi J, Yoon H . Renal hyperfiltration as a novel marker of all-cause mortality. J Am Soc Nephrol. 2014; 26(6):1426-33. PMC: 4446866. DOI: 10.1681/ASN.2014010115. View

14.

Ziuzia-Januszewska L, Januszewski M, Sosnowska-Nowak J, Janiszewski M, Dobrzynski P, Jakimiuk A . COVID-19 Severity and Mortality in Two Pandemic Waves in Poland and Predictors of Poor Outcomes of SARS-CoV-2 Infection in Hospitalized Young Adults. Viruses. 2022; 14(8). PMC: 9413321. DOI: 10.3390/v14081700. View

15.

Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, Coppens K . Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol. 2017; 5(12):986-1004. DOI: 10.1016/S2213-8587(17)30357-1. View

16.

Bivona G, Agnello L, Ciaccio M . Vitamin D and Immunomodulation: Is It Time to Change the Reference Values?. Ann Clin Lab Sci. 2017; 47(4):508-510. View

17.

Mariani J, Tajer C, Antonietti L, Inserra F, Ferder L, Manucha W . High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL). Trials. 2021; 22(1):111. PMC: 7848249. DOI: 10.1186/s13063-021-05073-3. View

18.

Li B, Yang S, Hou N . Could vitamin D supplementation play a role against COVID-19?. Front Immunol. 2022; 13:967215. PMC: 9511139. DOI: 10.3389/fimmu.2022.967215. View

19.

Haussler M, Jurutka P, Mizwicki M, Norman A . Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011; 25(4):543-59. DOI: 10.1016/j.beem.2011.05.010. View

20.

DAvolio A, Avataneo V, Manca A, Cusato J, De Nicolo A, Lucchini R . 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. Nutrients. 2020; 12(5). PMC: 7285131. DOI: 10.3390/nu12051359. View